theophylline

1
Reactions 621 - 5 Oct 1996 S Theophylline Death in an elderly patient after smoking cessation: case report A 65-year-old woman receiving oral sustained-release theophylline 200mg twice daily for emphysema [duration of therapy not stated] was hospitalised with toxic theophylline levels after she stopped smoking. The woman had a history of mild congestive heart failure and stroke and smoking > 90 packs of cigarettes per year. Nine months after she stopped smoking, the woman was hospitalised with a 3-week history of weakness, nausea and vomiting. During hospitalisation she developed atrial fibrillation unresponsive to electrical cardioversion, and seizures, and required ventilatory support for respiratory insufficiency. She then developed fever and leucocytosis. Her serum theophylline concentration was found to be elevated to 45.2 µg/ml (therapeutic range 10–20). The woman was treated with anticonvulsants, antibacterials, activated charcoal and magnesium citrate. By hospital day 4, her serum theophylline concentration had decreased to 7.1 µg/ ml and, 2 days later, she was extubated. That evening she developed a high fever, hypotension and hypoxia. She was reintubated and treated with dopamine, but died the following day. Author comment: When theophylline recipients stop cigarette smoking, their theophylline dosage needs to be reduced by a third or fourth, with careful monitoring of serum concentrations. Rao JK, et al. Smoking cessation and theophylline toxicity in an elderly patient with emphysema. P and T 21: 432-434 & 448, Aug 1996 - USA 800469301 1 Reactions 5 Oct 1996 No. 621 0114-9954/10/0621-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: dolien

Post on 18-Mar-2017

217 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: Theophylline

Reactions 621 - 5 Oct 1996

STheophylline

Death in an elderly patient after smoking cessation:case report

A 65-year-old woman receiving oral sustained-releasetheophylline 200mg twice daily for emphysema [duration oftherapy not stated] was hospitalised with toxic theophyllinelevels after she stopped smoking.

The woman had a history of mild congestive heart failureand stroke and smoking > 90 packs of cigarettes per year.Nine months after she stopped smoking, the woman washospitalised with a 3-week history of weakness, nausea andvomiting. During hospitalisation she developed atrialfibrillation unresponsive to electrical cardioversion, andseizures, and required ventilatory support for respiratoryinsufficiency. She then developed fever and leucocytosis. Herserum theophylline concentration was found to be elevated to45.2 µg/ml (therapeutic range 10–20).

The woman was treated with anticonvulsants, antibacterials,activated charcoal and magnesium citrate. By hospital day 4,her serum theophylline concentration had decreased to 7.1 µg/ml and, 2 days later, she was extubated. That evening shedeveloped a high fever, hypotension and hypoxia. She wasreintubated and treated with dopamine, but died the followingday.

Author comment: When theophylline recipients stopcigarette smoking, their theophylline dosage needs to bereduced by a third or fourth, with careful monitoring of serumconcentrations.Rao JK, et al. Smoking cessation and theophylline toxicity in an elderly patientwith emphysema. P and T 21: 432-434 & 448, Aug 1996 - USA 800469301

1

Reactions 5 Oct 1996 No. 6210114-9954/10/0621-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved